drugset / Trial / NCT03719612

DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY

NCT03719612 ↗

Phase 3 Completed 160 enrolled Lantheus Medical Imaging Syneos Health · collab
NaSingle-groupOpen-labelDiagnostic

Summary

This is a Phase 3, prospective, open-label, multicenter study to evaluate Left Ventricular Ejection Fraction (LVEF) measurement accuracy and reproducibility of DEFINITY® contrast-enhanced and unenhanced echocardiography as compared with non-contrast cardiac magnetic resonance imaging (CMR) used as the truth standard.

Timeline

Start
2018-12-28
Primary completion
2020-01-09
Completion
2020-01-09

Outcome

Missed primary endpoint

registry analysis (superiority test); Blinded Reader 1; p = 0.358; Mean Difference (Final Values) -0.38; t-test, 2 sided NCT03719612 ↗

registry analysis (superiority test); Blinded Reader 2; p = 0.804; Mean Difference (Final Values) -0.12; t-test, 2 sided NCT03719612 ↗

registry analysis (superiority test); Blinded Reader 3; p = 0.371; Mean Difference (Final Values) -0.33; t-test, 2 sided NCT03719612 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Definity Diagnostic / imaging agent — —

Indications